2022
DOI: 10.3389/fphar.2022.898574
|View full text |Cite
|
Sign up to set email alerts
|

The Involvement of Caspases in Neuroinflammation and Neuronal Apoptosis in Chronic Pain and Potential Therapeutic Targets

Abstract: Chronic pain is a common, complex and unpleasant sensation following nerve injury, tissue trauma, inflammatory diseases, infection and cancer. It affects up to 25% of adults and is increasingly recognized as the leading cause of distress, disability and disease burden globally. Chronic pain is often refractory to most current analgesics, thus emphasizing the requirement for improved therapeutic medications. It is of great importance to elucidate the specific pathogenesis of chronic pain with different etiologi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 131 publications
(126 reference statements)
1
8
0
Order By: Relevance
“…Reductions, being significant for 40 µg/mL, in high glucose-evoked neuropathy were obtained after Cortexin ® treatment. The finding that Cortexin ® prevents high glucose-mediated neuropathy in DRG neurons is supported by previous studies reporting neuroprotective actions of Cortexin ® [16] in diabetic polyneuropathy [10], inflammatory pain [12], and ischemic brain injury, which were regarded as rationale for this in vitro study. When Cortexin ® was applied in normoglycemic conditions.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…Reductions, being significant for 40 µg/mL, in high glucose-evoked neuropathy were obtained after Cortexin ® treatment. The finding that Cortexin ® prevents high glucose-mediated neuropathy in DRG neurons is supported by previous studies reporting neuroprotective actions of Cortexin ® [16] in diabetic polyneuropathy [10], inflammatory pain [12], and ischemic brain injury, which were regarded as rationale for this in vitro study. When Cortexin ® was applied in normoglycemic conditions.…”
Section: Discussionsupporting
confidence: 80%
“…In clinical setting, Cortexin ® has been shown to alleviate clinical symptoms of alcoholic and diabetic polyneuropathy [10]. Furthermore, Cortexin ® has been shown to exert neuroprotective effect by inhibition of the initiator caspase-8 [11], the mechanism has been shown to be involved in painful neuropathy [12]. It is plausible that Cortexin ® might prevent/treat diabetes-mediated sensory neuronal damage, improve peripheral neuropathy, and be useful for chronic neuropathic pain.…”
Section: Introductionmentioning
confidence: 99%
“…Macrophages or microglia are activated in response to noxious stimuli such as nerve injury. Activated macrophages or microglia result in the production and release of pro-inflammatory mediators, which lead to the development of chronic pain [ 98 , 99 ]. LPC induced macrophage and microglia recruitment and activation in the mouse spinal cord [ 100 , 101 , 102 ].…”
Section: Lysophosphatidylcholine and Chronic Pain Diseasesmentioning
confidence: 99%
“…In addition, the heterogeneity of neurotrauma creates additional difficulties in their study and difficulties in developing and selecting a competent treatment strategy [ 3 ]. In addition, CNS and PNS injuries often lead to various mental disorders [ 4 , 5 , 6 , 7 , 8 ] and neurodegenerative diseases [ 9 , 10 , 11 , 12 , 13 ], which are accompanied by increased cell death of the nervous tissue [ 14 , 15 , 16 , 17 , 18 , 19 ]. It is worth noting that nerve cells are very sensitive to various influences, including microwave radiation, which can cause neurodegenerative diseases [ 20 ].…”
Section: Introductionmentioning
confidence: 99%